Delhi HC: Non-Proof of Hearing Notice Dispatch Doesn’t by Itself Show no Personal Hearing Was Given  ||  Delhi High Court: No Construction or Residence Allowed on Yamuna Floodplains, Even For Graveyards  ||  J&K High Court: Right to Speedy Trial Includes Appeals; Closes 46-Year-Old Criminal Case Due to Delay  ||  J&K High Court: Courts Must Not Halt Corruption Probes, Refuses to Quash FIR  ||  J&K&L HC: Matrimonial Remedies May Overlap, But Cruelty Claims Cannot be Selectively Invoked  ||  Delhi High Court: Customs Officials Acting Officially Cannot be Cross-Examined as of Right  ||  J&K&L HC: Second Arbitral Reference is Maintainable if Award is Set Aside Without Deciding Merits  ||  J&K&L HC: Gold Voluntarily Given to Customer is 'Entrustment'; Theft Excluded from Insurance Cover  ||  Delhi HC: Working Mothers Cannot be Forced to Bear Full Childcare Burden While Fathers Evade Duty  ||  J&K&L HC: Arbitral Tribunal Not a “Court”; Giving False Evidence Before it Doesn’t Attract S.195 CrPC    

Allergan, Intas Pharma Settle Trademark Dispute over Usage of Trademarks Botox and BTX-A - (05 Oct 2015)

US-based Allergan Inc and Gujarat-based Intas Pharmaceuticals have entered into settlement over usage of trademarks Botox and BTX-A. Intas Pharma acknowledged Allergan's exclusive right for registered marks Botox and BTX-A, while the US-based firm accepted Intas' use of the mark BTXA without hyphen.

Tags : ALLERGAN   INTAS PHARMA  

Share :        

Disclaimer | Copyright 2025 - All Rights Reserved